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Abstract
A major limitation of synthetic bone repair is insufficient vascularization of the interior
region of the scaffold. In this study, we investigated the 3D printing of adipose derived
mesenchymal stem cells (AD-MSCs) with polycaprolactone (PCL)/bioactive glass composite in
a single process. This offered a three-dimensional environment for complex and dynamic
interactions that govern the cell’s behavior in vivo. Borate based bioactive (13-93B3) glass of
different concentrations (10 to 50 weight %) was added to a mixture of PCL and organic solvent
to make an extrudable paste. AD-MSCs suspended in Matrigel was extruded as droplets using a
second syringe. Scaffolds measuring 10x10x1 mm3 in overall dimensions with a filament width
of ~500 µm and pore sizes ranging from 100 to 200 µm were fabricated. Strut formability
dependence on paste viscosity, scaffold integrity, and printing parameters for droplets of ADMSCs suspended in Matrigel were investigated.
1. Introduction
Bone defects, resulting from trauma, cancer, arthritis, infection, or congenital skeletal
abnormalities, contribute to major surgeries performed every year. Autologous bone graft is still
considered as the golden standard for most applications but creates donor site morbidity [1, 2].
Allografts avoid these issues but have limited availability, concerns over immunogenicity, and
potential disease transmission [3]. Several types of materials, including biocompatible metals,
bioceramics, and biopolymers are currently being investigated as candidates for synthetic grafts.
Additive manufacturing of these materials has shown that complex and strong implants can be
made to treat different regions of bone, including load-bearing bone [4-6]. However, engineered
bone scaffolds have not been as successful as autologous grafts due to insufficient
vascularization and reduced biomechanical function [7, 8].
Borate based bioactive glasses are biocompatible, osteoconductive, and angiogenic. In
comparison to the more common silicate based bioactive glass, such as 45S5 or 13-93 glass,
bioactive borate glass (13-93B3) has a higher reaction rate (5-10 times faster than silicate
glasses); is more resorbable (60 to 70% wt. loss) in a few days to weeks; and is angiogenic,
antimicrobial, and osteo stimulatory/conductive [9]. Controlling the size of the glass particles
means the degradation rate of the glass can also be controlled to some extent. With the bioactive
glass, there is also the potential use of dopants that could increase the positive biological effects,
such as angiogenesis. In comparison, hydroxyapatite resorbs slowly and undergoes little
conversion to bone-like material after implantation and provides no flexibility to tailor the
material properties for the application. Biocompatible polymers such as polycaprolactone (PCL),
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provide strength and elasticity to scaffolds. PCL is one of the most widely used materials in 3D
printing for biomedical applications because of its low cost and excellent rheological and
viscoelastic properties [10]. Though PCL has a slow degradation rate (>2 years compared to few
months for poly(lactic acid)/poly(glycolic acid) copolymers), a composite scaffold of 13-93B3
and PCL may provide the benefits of both 13-93B3 glass and PCL materials.
Mesenchymal stem / progenitor cells (MSCs) have been used for cell therapy and in
tissue engineering because of their ability to differentiate into multiple mesenchymal lineages in
vitro, immune modulatory effects, and angiogenic capacity [11, 12]. MSCs have been isolated
from several tissues, including the bone marrow (BM-MSCs), adipose tissue (AD-MSCs), and
skin tissue [13-16]. The frequency of MSCs in adipose tissue is much higher than the more
commonly studied source of bone marrow, yielding 100 to 500 times more cells per tissue
volume [17, 18]. AD-MSCs have similar self-renewal abilities, common surface epitopes,
growth kinetics, and cytokine expression profiles to BM-MSCs. With the addition of MSCs, the
scaffold is expected to improve its biomechanical and biological properties in order to better
repair the target tissue.
Recent research has focused on creating living or cell-laden grafts for tissue engineering
[19-21]. In such techniques, cells or cell aggregates are dispersed, typically in a hydrogel, and
then deposited layer-by-layer and solidified either by thermal or chemical processes to form a
scaffold. Though such a scaffold holds promise in wound healing, drug delivery, and certain
tissue engineering applications, bone repair requires a certain amount of mechanical integrity and
controlled degradation of the scaffold which is difficult to accomplish. Traditionally, biopolymer
scaffolds are fabricated using the fused deposition modeling process, where a polymer is melted
and deposited thereby making it difficult to print cells alongside because of relatively high
working temperatures [7]. In this study, we investigate the feasibility of printing a 3D scaffold
using a two syringe system with a biopolymer/bioglass composite dissolved in an organic solvent
as a scaffold material whilst simultaneously printing cells suspended in Matrigel, a gelatinous
protein mixture representing basement membrane.
2. Materials and Methods
2.1 Preparation of PCL+bioactive glass composite
PCL (Sigma-Aldrich, St. Louis, MO) was dissolved in chloroform (Sigma-Aldrich, St.
Louis, MO) in a covered glass container with the help of a stirrer at ~50°C. The weight
percentage of PCL was varied from 1:1 to 5:4 (grams of PCL to mL of chloroform) to determine
the best possible ratio for printing. An appropriate ratio was established by visually inspecting
the paste and through filament extrusion using a digital syringe dispenser. Then, 13-93B3 borate
bioactive glass (Mo-Sci Corporation, Rolla, MO) (nominal composition – 53% B2O3, 20% CaO,
12% K2O, 6% Na2O, 5% MgO, 4% P2O5 in weight percentage) of size less than ~20 µm was
added to the PCL:chloroform mix in five different weight percentages in increments of 10,
ranging from 10% to 50%. A magnetic stirrer was used to uniformly mix the composite paste
and it was ensured that there was no glass particle precipitate before transferring the paste to a
syringe. Each ratio was tested using a Loctite® digital syringe dispenser (Henkel North America,
Rocky Hill, CT) at air pressures ranging from 10 to 50 psi with nozzle tips ranging from 110 to
500 µm.
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2.2 Scaffold fabrication
The PCL/glass scaffold (10 mm x 10 mm) was printed with 0-90° orientation of the
filaments in alternate layers, shown as schematic in Figure 1a. Printing was performed with an
assembled DIY 3D printer (Geeetech, Prusa I3 A Pro) which was modified to have two syringes
connected to digital syringe dispensers and are computer controlled. The 3D printer set-up is
shown in Figure 1b. The printing parameters such as filament spacing, layer height, printing
speed, etc. were identified based on visual inspection and optical microscopic images after a
single layer extrusion. Printing parameters such as needle tip size (260 µm) and printing speed (~
8 mm/s) were uniform for all paste concentrations. Parameters such as air pressure and filament
overlap are correspondingly modified for different pastes. Samples of 3D printed scaffolds were
sputter coated with gold/palladium (Au/Pd) for 60 s before performing scanning electron
microscopy (SEM). SEM (Hitachi S-4700 FESEM, Hitachi Co., Tokyo, Japan) images were
taken to evaluate the surface morphology of scaffolds and internal structure of the filaments.

Figure 1. (a) Schematic showing the fabrication of PCL+Bioglass filaments in 0-90 layer
orientation with cells suspended in Matrigel (red dots), (b) 3D printer set-up with digital syringe
dispensers
2.3 Preparation and printing of AD-MSCs
Different concentrations of Matrigel, diluted in phosphate buffered saline (PBS), ranging
from 4 mg/mL to 10 mg/mL were printed using 10 psi and a 160 µm (30G) diameter nozzle tip
to determine the ideal concentration for printing with cells. Frozen vials of approximately 1x106
AD-MSCs were obtained from three separate donors (LaCell, New Orleans, LA). Vials were
unthawed, plated on 150 cm2 culture dishes (Nunc, Rochester, NY) in 25 mL complete culture
media (CCM), and incubated at 37.5oC with 5% humidified CO2. After 24 hours, the media was
removed and adherent, viable cells were washed twice with PBS, harvested with 0.25% trypsin/
1mM EDTA (Gibco), and replated at 100 cells/cm2 in CCM. Media was changed every 3 to 4
days. For all experiments, sub-confluent cells (≤70% confluent) between passages 2 and 6 were
used.
After determining that a concentration of 9 mg/mL Matrigel yielded the preferred droplet
size, AD-MSCs at a concentration of 1x106 cells/mL were suspended in Matrigel. The printing
parameters for Matrigel+cells were tested by designing a blocked experiment with air pressure as
the blocked variable (10 and 20 psi). The other two variables considered were extrusion time
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(0.025 s and 0.035 s) and distance from the substrate (100 µm and 200 µm). A sample size of n =
3 was used for each droplet deposition with a specific set of parameters as shown in Table 1.
When printing with Matrigel, the nozzle, cells, pipette tips, and Matrigel were all kept on ice
until just before printing.
Table 1. Experimental set-up to determine the Matrigel+cell droplet parameters (n = 3)
Distance from substrate (µm) Dispensing time (s) Air pressure (psi)
100
0.025
10
200
0.025
10
100
0.035
10
200
0.035
10
100
0.025
20
200
0.025
20
100
0.035
20
200
0.035
20
2.4 Degradation of PCL+bioactive glass and AD-MSCs distribution in Matrigel
The degradation of the PCL/glass composite material was studied using a thin sheet of
the composite prepared by pouring the PCL/glass mixture on a polished glass plate and tape
casted using a doctor blade set at a thickness of 600 µm. The measured thickness of the dried
film was 60±10 µm. Samples measuring 3 cm x 3 cm were cut from the sheet and kept in 50 mL
of simulated body fluid (SBF) at 37°C. After the desired time intervals, the composite samples
were removed from SBF and dried at 50°C for 12 h. The weight loss of each sample was
measured and the SBF solution was analyzed by inductive coupled plasma spectroscopy (ICP)
for boron, silicon, calcium, and phosphorus. To analyze the MSC distribution in Matrigel, 4',6diamidino-2-phenylindole (DAPI) stain was used to image the Matrigel+cell droplets using
fluorescent microscopy.
2.5 Effect of Chloroform Evaporation on AD-MSC Viability
The effect of chloroform evaporation from the scaffold on the viability of the AD-MSCs
was studied by printing three layers of the 30% glass composite on a two chamber microscope
slide (Thermo Fischer Scientific, Rochester, NY) then printing a layer of AD-MSCs at a
concentration of 10x106 cells per mL of Matrigel. The composite was printed according to the
parameters given in Table 2 and the AD-MSCs were printed at 10 psi, 0.035 s dispensing time,
and 200 µm from the slide. Four droplets of cells suspended in Matrigel, about 0.4 mm in
diameter, were printed on each horizontal filament of the scaffold.
The Matrigel was allowed to polymerize at room temperature for 20 minutes then 1 mL
of CCM was added. The slides were then incubated at 37.5oC with 5% humidified CO2. After 2
hours, the cells were stained according to the directions given with life technologies
LIVE/DEAD Cell Imaging Kit (ref. R37601, Eugene, OR) and examined under a fluorescent
scope. This was repeated again after 24 hours on a different set of scaffolds.
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3. Results and Discussion
3.1 Fabrication of PCL+bioactive glass composite
Single layer tests: The weight percentage of PCL was varied from 1:1 to 5:4 (in grams of
PCL to mL of chloroform) to determine the best ratio for fabricating the scaffold. During the
initial set of tests, different compositions of paste were extruded using a hand-held syringe and
with the help of a digital dispenser by varying the nozzle tip and air pressure. An air pressure
between 30 and 50 psi provided uniform extrusion of the PCL+chloroform mixture. The ideal
ratio of PCL and chloroform was determined to be 5 g of PCL to 3 mL of chloroform, extruded
at 30 psi using a 260 μm (25G) nozzle tip. A larger tip size (>260 µm) would result in thick
filaments which are considered not beneficial for achieving faster scaffold degradation and
smaller pore size distribution in the scaffold. Afterwards, 10% 13-93B3 glass by weight was
added to the PCL+chloroform mixture and then extruded with the same set of parameters without
difficulty. Figure 2a to 2c shows the filament extrusion tests performed on a microscopic glass
slide with varying printing speeds. A reduced filament width (from 1.8 mm to 0.8 mm) can be
observed with increasing table speed, which was tested from 3 to 10 mm/s. The filament width is
also dependent upon the homogeneity of the mixture. Figure 2d shows a successful and
continuous single layer of a 15 cm x 15 cm scaffold with the filament spacing of 0.7 mm and a
printing speed of 8 mm/s.

0.8 mm

1.0 mm
1.8 mm

Figure 2. Single layer tests with (PCL+10% Glass) and different printing speeds (a) 3 mm/s, (b)
5 mm/s, (c) 10 mm/s, and (d) 8 mm/s (which is used for rest of the experiments).
Two layer tests: The filament height and spacing of the first layer would be crucial
parameters to print successive layers. Filament height would determine the layer height and
filament spacing would define how well the bridging occurs in successive layers. Figure 3a
shows the optical microscopic image of the cross-sections of the first layer filaments. The
average height of the filament (shown between the two arrows) was ~75 µm. The height of the
filaments for 40 wt% and 50 wt% compositions remained the same as long as the same nozzle tip
was used. The roundness of the filament improved with a smaller tip but because of the nozzle
clogging issues, all the experiments were carried out with a 260 µm tip. Therefore, a layer height
of 0.08 mm was used to fabricate subsequent scaffolds. Another important factor in this study is
the dwell time between consecutive layers as this allows the chloroform to evaporate thereby
allowing the previous layer to become dry. A longer dwell time (>5 min) would warp the layer
and a shorter dwell time (<1 min) is not sufficient for the layer to dry. Figures 3b and 3c show
the results of printing a second layer with no dwell time and with 1 min dwell time, respectively,
with a 0.8 mm filament spacing. The difficulty in bridging the second layer without dwell time
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can be noticed, which was substantially improved with 1 mm dwell time. Figure 3d shows the
bridging of second layer with 2.5 min of dwell time and 0.7 mm filament spacing.

Figure 3. (a) Cross-sectional view of the PCL/glass filament measuring ~75 µm in height, (b)
second layer printing with zero dwell time, (c) second layer printing with 1 min dwell time, and
(d) second layer printed on top of the layer shown in Figure 2d with 2.5 min dwell time
Multiple layer scaffolds: Based on the best printing parameters determined, scaffolds
with multiple layers were fabricated with all five PCL/glass compositions (10 to 50 weight
percentage of 13-93B3 glass). For compositions made with 40 wt% and 50 wt% glass, the
amount of chloroform required to obtain a pourable characteristic for the paste was 4 mL
(instead of 3 mL to 5 g of PCL). This is believed to be due to the increased viscosity of the paste
with increase in glass content. With the exception of the paste made with 30 wt% of glass, which
was extruded at an air pressure of 40 psi, remaining paste compositions were extruded at an air
pressure of 30 psi. The final set of parameters used to fabricate scaffolds is given in Table 2. The
filament width of 500±50 μm was measured for all compositions printed with a 260 µm nozzle
tip while the average pore size depended on the filament spacing. A spacing of 0.6 mm provided
pore sizes ranging from ~100 to ~200 μm while in scaffolds with a spacing of 0.7 mm, the pore
size varied from ~200 to ~300 μm. Figure 4a shows an optical microscopic image of a scaffold
fabricated with a filament spacing of 0.6 mm and with a smaller pore size distribution. As can be
seen, pore sizes could be adjusted by modifying the filament spacing, to a certain extent, to suit a
certain tissue engineering application of the fabricated scaffold. It is known that pore size is an
important aspect of the scaffolds that could potentially effect the bone growth after implantation
and it has been reported that pore sizes in the range of 100 to 300 µm are beneficial for bone
growth [8]. The scaffolds fabricated by our process have pores in the same range. Figure 4b
shows images of 10 mm x 10 mm scaffolds fabricated with 0.8 mm spacing.
Table 2. Final printing parameters for each of five PCL/glass paste compositions
13-93B3 Glass Air Pressure PCL:Chloroform Filament Spacing
(Wt. %)
(psi)
(g to mL)
(mm)
10
30
5:3
0.6 – 0.8
20
30
5:3
0.6 – 0.8
30
40
5:3
0.6 – 0.8
40
30
5:4
0.7 – 0.9
50
30
5:4
0.7 – 0.9
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Figure 4. (a) Optical microscopic image showing the pore size distribution (~150 µm) in a
scaffold fabricated with 0.6 mm filament spacing, (b) (L-R) pictures of representative scaffolds
made with 10% to 50% glass content; the bottom image shows the warpage of scaffolds
containing 10 to 30 wt.% glass with the red arrow indicating the space between the scaffold and
slide. No warpage is seen in 40% and 50% scaffolds; scaffold with 50 wt% glass is the thickest
fabricated (1 mm).
It should be noted that the maximum thickness (or height) of the scaffolds depends on the
degree of chloroform evaporation and the distance between layers. All of our experiments were
carried out at room temperature (64°F) where the variation in relative humidity (58-60%) was
not considered to be a major factor. Faster chloroform evaporation would produce warpage of
the fabricated scaffold, especially with some dwell time between the layers. Non-uniform
distribution of the PCL and glass is not believed to be one of the major factors of warpage as,
upon examination of the filaments’ microstructure when printed with the same syringe at
different time intervals, there was similar and uniform deposition of glass particles throughout
the matrix. Therefore, the chloroform evaporation and the percentage of PCL in the composite is
one of the crucial factors which determines the warpage. Increasing the glass content in the
composite would indirectly decrease the chloroform content and thereby aids in faster
evaporation and improves the filament rigidity. In this study, it was observed that after reaching
a thickness of about 0.64 mm (8 layers), the scaffolds being fabricated with 10% and 20% glass
exhibited warping which led to difficulty in printing successive layers (see Figure 4b). The
warpage in scaffolds made with 30% and 40% glass was less pronounced and thickness of 0.8
mm (10 layers) was obtained. The best results were achieved for 50% glass scaffolds as they
were successfully printed to 1 mm thickness (12 layers) and could possibly have successive
layers printed. Larger thicknesses were not attempted as the focus of this study is on the
feasibility of printing PCL/glass scaffold along with MSCs. Though the mechanical properties of
the scaffolds are not measured, it was observed that the ease of handling scaffolds improved with
increasing glass content. The scaffold made with 50% glass had enough strength to be safely
handled.
Microstructure of PCL/glass composite scaffolds: Figure 5 shows the scanning electron
micrographs of a couple of representative PCL/glass scaffolds made with 40 and 50 wt.% glass.
Figures 5a to 5c show the surface morphology of the filament with increasing magnification
(x30, x90, and x2000). It was interesting to observe that particles of bioglass are conspicuously
absent from the surface of filaments. No pores on the filament surface were detected even when
observed at a high magnification of x2000. Figures 5d to 5e show the filament fracture surface
with increasing magnification (x180, x1000, and x2000). Glass particles dispersed in the PCL
matrix can be seen in the interior. The dissolved PCL in chloroform encloses the glass particles
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and the surface tension effects between the steel nozzle tip and PCL during extrusion might
cause the presence of only PCL on the surface.

Figure 5. SEM images of the PCL/glass scaffolds. (a-c) Images with increased magnification
from L-R showing a smooth surface morphology of the filament (40% glass scaffold), (d-f)
Images with increased magnification from L-R (50% glass scaffold) (d) showing the fracture
surface, (e-f) porous cross-sectional area of the filament with PCL matrix and glass particles
3.2 Degradation of PCL+bioactive glass composite in Simulate Body Fluid
A “PCL+13-93B3 glass+chloroform” composite system has been studied in the recent
past by producing thin sheets (60±10 µm) of PCL/glass composite [22]. The 3 cm x 3 cm sheet
samples were soaked in SBF, dried overnight and weighed to measure their weight loss. The
results indicate that 13-93B3 glass in the PCL/glass sheet had fully reacted to form
hydroxyapatite (HA) in about 3 days. Figure 6 shows the weight loss percentages of the
composite sheets made with different glass contents (20B – 20 wt.%, 40B – 40 wt.%, and 50B –
50 wt.% of 13-93B3 glass). In all three composites, reaction of the borate glass occurred rapidly
during the first three to six days and then weight loss remains nearly constant. As expected, there
was no loss of weight after 14 days for PCL. Also, weight loss increases with the increasing
weight percentage of borate glass. The arrows on the right axis indicate the ideal weight loss for
each composite which is weight loss of the glass if it completely reacted in SBF to form
stoichiometric HA (Ca10(PO4)6(OH)2). A similar degradation profile for 3D printed composite
scaffolds with different glass compositions is expected.
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Figure 6. Weight loss for 50%, 40% and 20% glass compositions w.r.t weight loss of 100% PCL.
The arrows on the right indicate the ideal weight loss for each composite [22].
3.3 Dispensing AD-MSCs suspended in Matrigel
Experiments were conducted to print droplets of Dulbecco's Modified Eagle Medium
(DMEM) which contained suspended AD-MSCs. It was determined that a 110 μm (32G) nozzle
tip extruded droplets less than 500 µm suitable for printing either on top or alongside the
deposited PCL/glass filaments. However, the DMEM in the printed droplets would evaporate
quickly making it difficult for further investigation. Therefore, the option of using Matrigel as
the medium to suspend the MSCs was considered. The initial set of experiments included
dispensing the Matrigel droplets without cells with the syringe dispensing system set-up to
determine an appropriate concentration of Matrigel and droplet size. A concentration of 10
mg/mL Matrigel provided smaller drops (~100 μm), while 8 mg/mL Matrigel produced larger
drops (~500 μm), and 4 mg/mL Matrigel produced even larger drops (1 mm). In each case,
Matrigel provided a stable environment for the cells without drying (measured for up to 10
minutes). As the filament width of the scaffolds was measured between 400 to 500 µm, a
Matrigel concentration of 9 mg/mL was selected to be appropriate for generating droplets which
could be deposited on top of the filaments. Approximately 1x106 cells suspended in PBS were
pipetted in Matrigel. The AD-MSCs+Matrigel solution was then transferred just before printing
to a 160 μm nozzle tip which was stored on ice during the entire non-printing time. It is assumed
that the MSCs were uniformly distributed in the Matrigel before the start of the droplet
deposition.
An experiment was conducted to dispense Matrigel droplets with suspended MSCs by
varying parameters including distance of the nozzle tip from glass slide, dispensing time of
droplet, and air pressure. ImageJ software was utilized to quantify the number of cells in each
fluorescent image. Figure 6 shows DAPI stained images of Matrigel droplets with 1x106
cells/mL printed at different parameters. Figures 7a-7d show the fluorescent images of the
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Matrigel droplets printed with 10 psi air pressure and Figures 7e-7h show the Matrigel droplet
images printed with 20 psi air pressure. It can be clearly observed that droplets made at higher air
pressure have a blue ring (cells are identified by blue dots in Figure 7) indicating that cells are at
the boundary of the droplet because of the high pressure. This result is irrespective of the other
two parameters. Droplets printed at the low air pressure (10 psi) have a smaller diameter and
provide a more uniform distribution of cells. Such a distribution would be beneficial and the
droplet size (<500 µm) would be appropriate to print on the PCL/glass filament. Among the four
sets of droplets printed with 10 psi, it is observed that those printed with a distance offset of 200
µm had more cells (150 and 153) in comparison to those printed with an offset of 100 µm (105
and 148). Further, amongst the droplets printed with 200 µm offset distance and 10 psi pressure,
the droplets printed with a pulse time of 0.035 s was measured to have slightly higher cell count
(153) in comparison to those printed at 0.025 s (150). These results allow us to determine the
printing parameters for depositing Matrigel droplets, which are: (i) air pressure of 10 psi, (ii)
distance from glass slide of 200 µm, and (iii) pulse duration of 0.035 s. Figure 6a shows a
Matrigel droplet printed with the above set of parameters. Select cells are marked using arrows
for better comprehension of the image in print. Investigating the cell survivability on the
“PCL+13-93B3 glass+chloroform” filament is a crucial step toward our goal of establishing a
novel and successful method of 3D printing of scaffolds with living cells for tissue engineering.
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Figure 7. DAPI stained fluorescent images of AD-MSC/Matrigel droplets, printed at (a-d) 10 psi
and (e-h) 20 psi air pressure. (a) A pulse time of 0.035 s and 200 µm distance from glass slide (b)
0.025 s and 200 µm (c) 0.035 s and 100 µm (d) 0.025 s and 100 µm. The cells are at the
boundary of the droplet because of higher air pressure.
3.4 Effect of Chloroform Evaporation on AD-MSC Viability
Viability of AD-MSC after printing was determined by a live/dead assay 2 and 24 hours
after printing (Figure 8). At two hours, 96% were viable, demonstrating a minimal negative
effect on the cells shortly after printing. At 24 hours, 65% were viable, indicating the potential
for long term growth of the cells.

a

b

100
100
µm
µm
Figure 8. Live/Dead images of AD-MSC/Matrigel droplets
printed on 3 layers of the 30%

glass PCL composite. Imaged after (a) 2 hours and (b) 24 hours. The yellow square indicates a
pore in the scaffold.
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4. Conclusion
This study investigated the feasibility of fabricating a scaffold with polycaprolactone
(PCL) and 13-93B3 bioactive borate glass composite utilizing a 3D printer without any heat
input. This method would allow the process to incorporate cells during the printing of a scaffold
unlike other processes where heating of the biopolymer is involved. Scaffolds were printed and
near optimal printing parameters for each of the five different PCL/glass compositions were
determined. Scaffolds fabricated with a 50:50 (in weight percentage) PCL/glass composite
utilizing the parameters of 30 psi, 5 g of PCL to 4 mL of chloroform, 0.8 mm filament spacing
were easy to handle with sufficient mechanical integrity. Printing parameters for depositing cells
suspended in Matrigel were determined and uniform distribution of cells in a ~400 µm droplet
size was obtained for an air pressure of 10 psi and 0.035 s pulse. A live/dead assay performed 2
and 24 hours after printing cells on a 3 layer scaffold showed minimal negative effects from
chloroform evaporation on the cells. The results of this study show the potential of the process to
fabricate a scaffold with living cells embedded for tissue engineering applications.
A continuation of this study would include increasing the height of the scaffold. To
achieve this, the scaffold fabrication process will be modified by avoiding the continuous
printing of the single layer and incorporating start-stop operations to deposit each filament in the
layer. Such an operation would avoid the excess build-up of material at the scaffold edge which
aids in building thicker scaffolds. The objective of this study is to simultaneously print the MSCs
and PCL+glass. Therefore, the viability of printing MSCs based on the height of the scaffold will
also be investigated. The degradation of the PCL+glass scaffolds is a work in progress and
despite its known hydrophobicity, the initial results indicate that DI water/cell culture media is
able to penetrate PCL and helps in glass dissolution. In this context, it is believed that the
fabricated scaffolds tend to be more porous than the designed porosity of ~50%. Further
experiments will be performed to investigate the overall scaffold porosity. In relation to cell
viability, a live/dead assay will be performed for 24 hours, 1 week, and 2 weeks with the 50%
glass composition.
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